This is also corroboratory of our recently published work wherein we suggested a correlation between high CDH11 Expression and the poor overall survival rates in patients with basal-like and triple negative breast cancer based on big data analysis [11]. This evidence concerns the gene CDH11 and triple-negative breast carcinoma.